Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors

BACKGROUND: Thyroid immune-related adverse events (IRAEs) have been reported in patients treated with programmed cell death protein-1 (PD-1) and programmed cell death protein-ligand 1 (PD-L1) inhibitors. We investigated the incidence and clinical course of PD-1/PD-L1 inhibitor-induced thyroid IRAEs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jee Hee, Hong, A Ram, Kim, Hee Kyung, Kang, Ho-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090457/
https://www.ncbi.nlm.nih.gov/pubmed/33820396
http://dx.doi.org/10.3803/EnM.2020.906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090457/
https://www.ncbi.nlm.nih.gov/pubmed/33820396
http://dx.doi.org/10.3803/EnM.2020.906

Ejemplares similares